Notice of Intent

Added: May 27, 2016 1:46 pm This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Fixed Price Purchase Order to Cellgenix USA, Portsmouth, NH 038012, on a sole source basis to procure Recombinant Human Interleukin-4 (rec.hu.IL-4) as necessary to fulfill the requirements of protocols underway at the NIH, Clinical Center. The Government intends to purchase 70 vials with options to purchase up to four (4) more orders of 35 vials each as separately priced line items within a 12 month Period of Performance. It is essential to the integrity of the protocol that the source of the rec.hu.IL-4 come from the same source as that which was used previously in the protocols so as not to introduce variables harmful to the findings of the protocols.

This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12 in conjunction with the policies and procedures for the competition requirements in FAR Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Lisa Schaupp, Contract Specialist, Lisa.Schaupp@nih.gov, by the due date and time marked in this notice.